Accel Synthesis
Contract research news in brief
January 5, 2011Research and Development Accel Synthesis, Almac, Bioanalytical Systems, Caliper Life Sciences, Cambridge Research & Instrumentation, Critical Path Services, Pharmasset, ReSearch Pharmaceutical Services, ResourcingPoint, Warburg Pincus
Private equity firm Warburg Pincus buys RPS for $227 million, plus updates from BASi, Almac, Caliper, and Critical Path Services/Accel …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
